Metformin reduced thyroid volume in patients with type 2 diabetes [105], likely due to direct inhibition of thyroid growth by activation of the AMPK/ mTOR pathway and antagonizing the growth-stimulatory effect of insulin by inhibition of the MAPK pathway [104]. Here, INS is linked to type 2 diabetes mellitus.